VLASCOVIA VELASCO RIOS: Open Payments
NPI 1396923454 · CERES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 38 payments from 14 companies in 2025. Trend: 2023 $486 · 2024 $840 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $161 |
| Lilly USA, LLC | 5 | $77 |
| Exact Sciences Corporation | 2 | $51 |
| Abbott Laboratories | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Corcept Therapeutics | 2 | $38 |
| Hologic Sales and Service, LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: EVENITY, MOUNJARO, TEZSPIRE, FREESTYLE LIBRE 3, REXULTI, Korlym, Cologuard Collection Kit, APTIMA.
Industry payments across CA — which companies pay providers there.
